Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
IP.com Launches IQ Ideas+ 3.0: Revolutionizing Ideation with AI-Powered Innovation to Maximize ROI in R&D
-
DXC Technology Bolsters Leadership with Kaveri Camire as Chief Marketing Officer
-
Hess Announces New Mini Toy Truck Collection
-
Introducing Abe, a Plain, Honest and Borrower-Supportive Student Loan Product
-
Alexandria Real Estate Equities, Inc. Declares Cash Dividend of $1.30 per Common Share for 2Q24, an Increase of 3 Cents Over 1Q24, and an Aggregate of $5.08 per Common Share for the 12 Months Ending J
-
Deloitte named a Leader in 2024 Gartner® Magic Quadrant™ for Finance & Accounting Business Process Outsourcing
-
ChurnZero launches survey for 2024 Customer Success Leadership Study
-
CallMiner Launches the CallMiner App Marketplace to Help Organizations Expand the Value of Conversation Intelligence Investments
-
AKM Achieves Successful Proof of Concept for eFuse in High Voltage 800 V Automotive Applications
-
Sengenics Corporation Announces New Collaboration to Advance Cancer Treatment
-
electroCore, Inc. Announces $9.3 Million Registered Direct Offering and Concurrent Private Placements Priced At Market Under Nasdaq Rules
-
Align Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research
-
Energy Vault Executes EPC and O&M Contract with ACEN Australia for 200 MW/400 MWh of Battery Energy Storage Deployments
-
Best’s Special Report: US Individual Annuity Writers Saw Highest Premium Growth in Decade in 2023
-
Ramirez Asset Management Launches Government Money Market Fund in Partnership with the Hispanic Scholarship Fund
-
State Street Global Advisors Study: Advisors Capture Four Influential Investor Segments With A Combination of Old Fashioned Collaboration and Modern Technology
-
Cintas Recognized as One of America’s Best Employers for New Graduates by Forbes
-
Amprius Sets June 2024 Events Schedule
-
Safety Shot, World’s First Beverage to Reduce Blood Alcohol Content, Announces Launch of New 4-Ounce Bottles
-
TIAN RUIXIANG Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement and Receives an Extension on Compliance with Nasdaq Filing Requirement
-
Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
-
FDA Provides Feedback and Reaches Consensus on Nexalin’s Design for Planned Anxiety and Insomnia Clinical Studies of its Gen-3 HALO Clarity™ Headset Device
-
LIXTE Biotechnology Holdings Names Distinguished Oncologist Jan Schellens as Chief Medical Officer
-
Qlik Signs Strategic Collaboration Agreement with AWS to Accelerate Enterprise AI Adoption
-
Beyond, Inc. to Participate in Upcoming Investor Conferences
-
Electric Metals (USA) Limited Further Strengthens its Board of Directors
-
Zion Oil & Gas, Inc. Announces Start of Recompletion Operations for our MJ-01 Well in Israel
-
Lowe's Pioneers a New Era of In-Store Kitchen Design with Apple Vision Pro
-
Paul Hastings Adds Premier Restructuring and Private Credit Team, Further Strengthening Market-Leading Restructuring and Finance Platforms
-
The Seasons Games - An immersive experience at the Théâtre du Lido des Champs-Elysées in Paris
-
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
LCS Announces 2024 Chef of the Year Finalists
-
Ensysce Biosciences to Participate in the EPHMRA 2024 Annual Meeting
-
Form 8.3 - Irish Residential Properties REIT plc
-
Genflow Biosciences PLC Announces Notice of AGM
-
Stillwater Critical Minerals Appoints Glencore’s Bradley Adamson to its Board of Directors
-
Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
-
GameSquare Sells Non-Core Content Management Software and PR Media Distribution Assets
-
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survi
-
Report on transactions of executives and related parties in ROCKWOOL A/S shares
-
Hi-Tech Pharmaceuticals: Increases Capacity on Precision Protein™ Hydrolyzed Whey
-
Eagle Royalties Appoints New Chief Financial Officer
-
Zedge To Report Third Fiscal Quarter 2024 Results
-
Procure Disaster Recovery Strategy ETF (NASDAQ:FIXT) Up 35% Since Launch
-
CNS Pharmaceuticals Announces Reverse Stock Split
-
Focus Announces That Five U.S. Business Lines of Connectus Wealth Advisers Have Joined The Colony Group
-
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
-
Thermo Fisher Scientific Unveils New Solutions Supporting Research Workflows at ASMS 2024
-
Equitable Holdings Announces Cash Tender Offer for Up to $500 Million Aggregate Purchase Price of Its Debt Securities
